Jun 1, 2026 11:00AM
Jun 1, 2026 11:00AM
May 14, 2026 09:15AM
May 5, 2026 06:00AM
Apr 30, 2026 06:01AM
Apr 30, 2026 06:00AM
Apr 13, 2026 01:29PM Ideaya Biosciences (IDYA) PT Raised to $35 at Goldman Sachs
Apr 13, 2026 06:00AM
Apr 13, 2026 06:00AM
Mar 23, 2026 04:56AM
Feb 17, 2026 06:00AM
Feb 6, 2026 04:45AM
Jan 11, 2026 12:00PM
Dec 11, 2025 06:00AM IDEAYA completes enrollment in phase 2/3 uveal melanoma trial
Dec 11, 2025 06:00AM
Dec 10, 2025 06:01AM
Dec 10, 2025 06:00AM
Dec 4, 2025 07:00PM
Dec 1, 2025 06:00AM
Dec 1, 2025 06:00AM
Nov 4, 2025 06:00AM IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
Oct 20, 2025 06:30AM
Oct 20, 2025 06:30AM
Oct 7, 2025 07:53AM
Sep 11, 2025 08:18AM
Sep 8, 2025 08:00AM
Sep 8, 2025 08:00AM
Sep 3, 2025 06:00AM IDEAYA Biosciences submits IND for PRMT5 inhibitor IDE892
Sep 3, 2025 06:00AM
Sep 2, 2025 06:01AM
Sep 2, 2025 06:00AM
Aug 5, 2025 06:00AM
Jul 24, 2025 09:25AM
Jul 24, 2025 09:25AM
May 6, 2025 06:05AM IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 6, 2025 06:01AM
May 6, 2025 06:00AM
Apr 14, 2025 06:00AM
Apr 14, 2025 06:00AM
Mar 31, 2025 06:29AM
Mar 31, 2025 06:00AM
Feb 13, 2025 06:05AM IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Jan 2, 2025 04:00PM
Dec 21, 2024 10:00AM
Dec 17, 2024 06:00AM
Dec 16, 2024 06:04AM
Dec 16, 2024 06:00AM
Dec 10, 2024 06:01AM
Dec 10, 2024 06:00AM IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
Dec 9, 2024 06:00AM

322,913 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All